Anh Duc Pham
- Name
- A.D. Pham
- ORCID iD
- 0000-0002-0279-1761
- Higazy D., Pham A.D., Hasselt C. van, Høiby N, Jelsbak L., Moser C. & Ciofu O. (2024), In vivo evolution of antimicrobial resistance in a biofilm model of Pseudomonas aeruginosa lung infection, The ISME Journal 18(1): wrae036.
- Os W. van, Pham A.D., Eberl S., Minichmayr I.K., Hasselt J.G.C. van & Zeitlinger M. (2024), Integrative model-based comparison of target site-specific antimicrobial effects: a case study with ceftaroline and lefamulin, International Journal of Antimicrobial Agents 63(5): 107148.
- Os W. van, Nussbaumer-Pröll A., Pham A.D., Wijnant G.J., Ngougni Pokem P., Bambeke F. Van, Hasselt J.G.C. van & Zeitlinger M. (2024), Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections, Journal of Antimicrobial Chemotherapy 79(10): 2484-2492.
- Sanz-Codina M., Os W. van, Pham A.D., Jorda A., Wölfl-Duchek M., Bergmann F., Lackner E., Lier C., Hasselt J.G.C. van, Minichmayr I.K., Dorn C., Zeitlinger M. & Al Jalali V. (2024), Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers, Journal of Antimicrobial Chemotherapy 79(12): 3281-3288.
- Al Jalali V., Matzneller P., Pham A.D., Os W. van, Wölfl-Duchek M., Sanz-Codina M., Vychytil A., Reiter B., Stimpfl T. & Zeitlinger M. (2023), Plasma and intraperitoneal pharmacokinetics of ceftazidime/avibactam in peritoneal dialysis patients, Clinical Microbiology and Infection 29(9): 1196.e1-1196.e7.